To date, the gold standard for the diagnosis of NSIAD is the sequencing of the AVPR2 gene in patients with otherwise unexplainable euvolemic hyponatremia. The gene discussed is AVPR2; the disease is nephrogenic syndrome of inappropriate antidiuresis.